Sanofi and PATH Announce Large-Scale Production Line of Semisynthetic Artemisinin

Sanofi and PATH Announce Large-Scale Production Line of Semisynthetic Artemisini

According to an April 11 press release, Sanofi and PATH's Drug Development program have announced the launch of large-scale production line of semisynthetic artemisinin. The large-scale production line will be launched at Sanofi's Garessio site in Italy.

World Health Organization's revelation about high effectiveness of artemisinin-based combination therapies in treating malaria has triggered a global demand for artemisinin. This semisynthetic route will enable a more consistent supply than to the botanical supply of artemisinin.

It is a triumph for malaria treatment as synthetic version of the world's most effective anti-malarial drug, artemisinin, can now be made in just three weeks instead of 18 months.

Scientists have reported that despite the success of artemisinin, the malaria parasite is developing resistance to it. They said that combination of artemisinin with other drugs is a way to battle the resistance development against drugs.

The commercial-scale alternative manufacturing process to produce artermisnin began nine year ago. OneWorld Health, a nonprofit drug-development organization, led the partnership that established PATH's Drug Development program.

Bill & Melinda Gates Foundation funded the organization to produce low price drugs for developing countries. The project was built upon synthetic biology work by Dr. Jay Keasling at the University of California, Berkeley. It also involved a team of public and private partners, including Sanofi and synthetic biology innovator Amyris.

FrenchTribune Specials

Merck’s lung cancer drug earns FDA’s approval

The gap between men’s and women’s drinking habits has almost closed and women are now consuming nearly as much alcohol as men, results of a new worldwide survey revealed.

In the past, men were far more likely than women to consume alcohol to the limit that it starts affecting their health. Older researchers found as much as a twelve-...

Most Popular

T-Mobile agrees to pay $48M to resolve FCC’s investigation into its unlimited da

US wireless carrier T-Mobile has agreed to a $48 million...

National Prescription Drug Take-Back Day to take place on Saturday

The Drug Enforcement Administration’s National...

Dutch Road Traffic Service reflects on Tesla's use of the term 'Autopilot'

On Monday, the Dutch Road Traffic Service (RDW) said in...

Americans should take fresh look at Medicare options every year: experts say

People with Medicare coverage should make a yearly habit...


Can Greece Come out of Economic Problems: